Eun Joo Noh

468 total citations
10 papers, 409 citations indexed

About

Eun Joo Noh is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Eun Joo Noh has authored 10 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Eun Joo Noh's work include Histone Deacetylase Inhibitors Research (6 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related Molecular Pathways (3 papers). Eun Joo Noh is often cited by papers focused on Histone Deacetylase Inhibitors Research (6 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related Molecular Pathways (3 papers). Eun Joo Noh collaborates with scholars based in South Korea, United States and Canada. Eun Joo Noh's co-authors include Jong‐Soo Lee, Jong-Soo Lee, Gajin Jeong, Dae‐Sik Lim, Kyeong Sook Choi, Seung Up Kim, Eun Hee Kim, Kwang‐Lae Hoe, Joo‐Hyun Nam and Yong Cheol Hong and has published in prestigious journals such as Applied Physics Letters, Cancer Research and Oncogene.

In The Last Decade

Eun Joo Noh

10 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eun Joo Noh South Korea 10 289 93 61 43 42 10 409
Naman B. Shah United States 6 301 1.0× 44 0.5× 30 0.5× 31 0.7× 12 0.3× 6 475
Armin Sepp United Kingdom 13 301 1.0× 63 0.7× 183 3.0× 39 0.9× 12 0.3× 36 484
Mesfin Gewe United States 8 217 0.8× 104 1.1× 78 1.3× 44 1.0× 12 0.3× 10 379
Rendall R. Strawbridge United States 9 344 1.2× 37 0.4× 150 2.5× 23 0.5× 17 0.4× 24 533
Scott Simanski United States 14 400 1.4× 95 1.0× 79 1.3× 60 1.4× 43 1.0× 22 487
Peter Stenlund Sweden 9 309 1.1× 31 0.3× 65 1.1× 33 0.8× 11 0.3× 9 412
Lingbo Sun China 13 364 1.3× 33 0.4× 48 0.8× 14 0.3× 23 0.5× 21 475
Shuichiro Sato Japan 15 309 1.1× 142 1.5× 47 0.8× 50 1.2× 17 0.4× 22 542
Shahar Rotem‐Bamberger Israel 9 258 0.9× 41 0.4× 36 0.6× 23 0.5× 24 0.6× 13 333
Glenn N. Major United Kingdom 14 280 1.0× 42 0.5× 67 1.1× 37 0.9× 92 2.2× 22 508

Countries citing papers authored by Eun Joo Noh

Since Specialization
Citations

This map shows the geographic impact of Eun Joo Noh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eun Joo Noh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eun Joo Noh more than expected).

Fields of papers citing papers by Eun Joo Noh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eun Joo Noh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eun Joo Noh. The network helps show where Eun Joo Noh may publish in the future.

Co-authorship network of co-authors of Eun Joo Noh

This figure shows the co-authorship network connecting the top 25 collaborators of Eun Joo Noh. A scholar is included among the top collaborators of Eun Joo Noh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eun Joo Noh. Eun Joo Noh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lee, Sook-Jeong, Eun Joo Noh, Dong-Uk Kim, et al.. (2014). Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells. Experimental & Molecular Medicine. 46(2). e76–e76. 20 indexed citations
2.
Kim, Kangil, et al.. (2011). Atmospheric-pressure plasma-jet from micronozzle array and its biological effects on living cells for cancer therapy. Applied Physics Letters. 98(7). 60 indexed citations
3.
Park, Jeong‐Yeol, et al.. (2010). The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells. Journal of Gynecologic Oncology. 21(4). 262–262. 58 indexed citations
4.
Noh, Eun Joo, Dae‐Sik Lim, Gajin Jeong, & Jong-Soo Lee. (2008). An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner. Biochemical and Biophysical Research Communications. 378(3). 326–331. 64 indexed citations
5.
Noh, Eun Joo, Dae‐Sik Lim, & Jong-Soo Lee. (2008). A novel role for methyl CpG-binding domain protein 3, a component of the histone deacetylase complex, in regulation of cell cycle progression and cell death. Biochemical and Biophysical Research Communications. 378(3). 332–337. 10 indexed citations
6.
Noh, Eun Joo, Eun Ryoung Jang, Gajin Jeong, et al.. (2005). Methyl CpG–Binding Domain Protein 3 Mediates Cancer-Selective Cytotoxicity by Histone Deacetylase Inhibitors via Differential Transcriptional Reprogramming in Lung Cancer Cells. Cancer Research. 65(24). 11400–11410. 18 indexed citations
8.
Noh, Eun Joo, Heejung Jung, Gajin Jeong, et al.. (2004). Subcellular localization and transcriptional repressor activity of HBx on p21WAF1/Cip1 promoter is regulated by ERK-mediated phosphorylation. Biochemical and Biophysical Research Communications. 319(3). 738–745. 14 indexed citations
9.
Noh, Eun Joo & Jong‐Soo Lee. (2003). Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2–M transition. Biochemical and Biophysical Research Communications. 310(2). 267–273. 50 indexed citations
10.
Noh, Eun Joo, et al.. (2002). Characterization of Mycoplasma Arginine Deiminase Expressed in E. coli and Its Inhibitory Regulation of Nitric Oxide Synthesis. Molecules and Cells. 13(1). 137–143. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026